LeadingBiotech: Cancer Advance is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Shakti Narayan, Ph.D.
CBO at Tango Therapeutics


Shakti Narayan, PhD, JD, joined Tango Therapeutics as CBO in October 2017, bringing executive leadership experience in business development, operational & legal roles within the biotech and pharma industries. Shakti was most recently vice president, head of transactions at Johnson & Johnson Innovation (Boston), where he helped build J&J’s Innovation Centers model, led oncology business development efforts and led a team of deal-makers who drove transactions for multiple J&J businesses. These efforts were aimed at accessing early-stage products and innovation from outside J&J to help build the company’s pipeline strategically.

He previously led business development as part of the management team at Nodality, a VC-backed personalized medicine biotechnology company, where he developed the company’s partnering strategy, led and closed multiple big pharma strategic collaborations and held various operational roles. He began his career in business development at Genentech and as a life sciences transactional attorney at Wilson Sonsini Goodrich & Rosati.

Shakti earned his Bachelor of Arts in biology from Grinnell College. He earned a doctorate in cellular and molecular biology at the University of Wisconsin-Madison and the Salk Institute, and he was a post-doctoral scientist at Stanford University. His legal studies were completed at the University of California – Berkeley School of Law, where he earned a JD.

Shakti Narayan, Ph.D.'s Network

Agenda Sessions

  • Strategic Immuno-Oncology Collaboration: Spotlight on Tango Therapeutics